RheumaGen

RheumaGen

Biotechnology Research

Denver, Colorado 328 followers

RheumaGen is developing an HLA gene editing platform to cure Rheumatoid Arthritis and other autoimmune diseases.

About us

RheumaGen is developing a breakthrough gene editing treatment that has the potential to cure Rheumatoid Arthritis.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Denver, Colorado
Type
Privately Held
Founded
2019
Specialties
Gene Therapy

Locations

Employees at RheumaGen

Similar pages

Funding

RheumaGen 1 total round

Last Round

Series unknown

US$ 4.9M

See more info on crunchbase